61 related articles for article (PubMed ID: 19914076)
1. Aminopyridinecarboxamide-based inhibitors: Structure-activity relationship.
Bonafoux DF; Bonar SL; Clare M; Donnelly AM; Glaenzer JL; Guzova JA; Huang H; Kishore NN; Koszyk FJ; Lennon PJ; Libby A; Mathialagan S; Oburn DS; Rouw SA; Sommers CD; Tripp CS; Vanella LJ; Weier R; Wolfson SG; Huang HC
Bioorg Med Chem; 2010 Jan; 18(1):403-14. PubMed ID: 19914076
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of inflammatory cytokine production from rheumatoid synovial fibroblasts by a novel IkappaB kinase inhibitor.
Tsuchiya A; Imai K; Asamitsu K; Waguri-Nagaya Y; Otsuka T; Okamoto T
J Pharmacol Exp Ther; 2010 Apr; 333(1):236-43. PubMed ID: 20053934
[TBL] [Abstract][Full Text] [Related]
3. 3,5-Disubstituted-indole-7-carboxamides: the discovery of a novel series of potent, selective inhibitors of IKK-β.
Miller DD; Bamborough P; Christopher JA; Baldwin IR; Champigny AC; Cutler GJ; Kerns JK; Longstaff T; Mellor GW; Morey JV; Morse MA; Nie H; Rumsey WL; Taggart JJ
Bioorg Med Chem Lett; 2011 Apr; 21(8):2255-8. PubMed ID: 21429745
[TBL] [Abstract][Full Text] [Related]
4. A selective small molecule IkappaB Kinase beta inhibitor blocks nuclear factor kappaB-mediated inflammatory responses in human fibroblast-like synoviocytes, chondrocytes, and mast cells.
Wen D; Nong Y; Morgan JG; Gangurde P; Bielecki A; Dasilva J; Keaveney M; Cheng H; Fraser C; Schopf L; Hepperle M; Harriman G; Jaffee BD; Ocain TD; Xu Y
J Pharmacol Exp Ther; 2006 Jun; 317(3):989-1001. PubMed ID: 16525037
[TBL] [Abstract][Full Text] [Related]
5. Inhibition by a selective IkappaB kinase-2 inhibitor of interleukin-1-induced collagen degradation by corneal fibroblasts in three-dimensional culture.
Kondo Y; Fukuda K; Adachi T; Nishida T
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4850-7. PubMed ID: 18676628
[TBL] [Abstract][Full Text] [Related]
6. An anti-inflammatory mechanism of taurine conjugated 5-aminosalicylic acid against experimental colitis: taurine chloramine potentiates inhibitory effect of 5-aminosalicylic acid on IL-1beta-mediated NFkappaB activation.
Joo K; Lee Y; Choi D; Han J; Hong S; Kim YM; Jung Y
Eur J Pharmacol; 2009 Sep; 618(1-3):91-7. PubMed ID: 19616541
[TBL] [Abstract][Full Text] [Related]
7. A novel, highly selective, tight binding IkappaB kinase-2 (IKK-2) inhibitor: a tool to correlate IKK-2 activity to the fate and functions of the components of the nuclear factor-kappaB pathway in arthritis-relevant cells and animal models.
Mbalaviele G; Sommers CD; Bonar SL; Mathialagan S; Schindler JF; Guzova JA; Shaffer AF; Melton MA; Christine LJ; Tripp CS; Chiang PC; Thompson DC; Hu Y; Kishore N
J Pharmacol Exp Ther; 2009 Apr; 329(1):14-25. PubMed ID: 19168710
[TBL] [Abstract][Full Text] [Related]
8. Use of molecular imaging to quantify response to IKK-2 inhibitor treatment in murine arthritis.
Izmailova ES; Paz N; Alencar H; Chun M; Schopf L; Hepperle M; Lane JH; Harriman G; Xu Y; Ocain T; Weissleder R; Mahmood U; Healy AM; Jaffee B
Arthritis Rheum; 2007 Jan; 56(1):117-28. PubMed ID: 17195214
[TBL] [Abstract][Full Text] [Related]
9. Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-1beta.
Onodera S; Nishihira J; Koyama Y; Majima T; Aoki Y; Ichiyama H; Ishibashi T; Minami A
Arthritis Rheum; 2004 May; 50(5):1437-47. PubMed ID: 15146413
[TBL] [Abstract][Full Text] [Related]
10. Novel derivatives of ISO-1 as potent inhibitors of MIF biological function.
Balachandran S; Rodge A; Gadekar PK; Yadav VN; Kamath D; Chetrapal-Kunwar A; Bhatt P; Srinivasan S; Sharma S; Vishwakarma RA; Dagia NM
Bioorg Med Chem Lett; 2009 Aug; 19(16):4773-6. PubMed ID: 19592246
[TBL] [Abstract][Full Text] [Related]
11. Validation of the anti-inflammatory properties of small-molecule IkappaB Kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle.
Catley MC; Sukkar MB; Chung KF; Jaffee B; Liao SM; Coyle AJ; Haddad el-B; Barnes PJ; Newton R
Mol Pharmacol; 2006 Aug; 70(2):697-705. PubMed ID: 16687566
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the suppressive actions of glucosamine on the interleukin-1beta-mediated activation of synoviocytes.
Hua J; Sakamoto K; Kikukawa T; Abe C; Kurosawa H; Nagaoka I
Inflamm Res; 2007 Oct; 56(10):432-8. PubMed ID: 18026701
[TBL] [Abstract][Full Text] [Related]
13. IkappaB kinase-2-independent and -dependent inflammation in airway disease models: relevance of IKK-2 inhibition to the clinic.
Birrell MA; Wong S; Hardaker EL; Catley MC; McCluskie K; Collins M; Haj-Yahia S; Belvisi MG
Mol Pharmacol; 2006 Jun; 69(6):1791-800. PubMed ID: 16517756
[TBL] [Abstract][Full Text] [Related]
14. Suppression by Curcuma comosa Roxb. of pro-inflammatory cytokine secretion in phorbol-12-myristate-13-acetate stimulated human mononuclear cells.
Sodsai A; Piyachaturawat P; Sophasan S; Suksamrarn A; Vongsakul M
Int Immunopharmacol; 2007 Apr; 7(4):524-31. PubMed ID: 17321476
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel 2-(aminoheteroaryl)-thiazole-5-carboxamides as potent and orally active Src-family kinase p56(Lck) inhibitors.
Chen P; Norris D; Das J; Spergel SH; Wityak J; Leith L; Zhao R; Chen BC; Pitt S; Pang S; Shen DR; Zhang R; De Fex HF; Doweyko AM; McIntyre KW; Shuster DJ; Behnia K; Schieven GL; Barrish JC
Bioorg Med Chem Lett; 2004 Dec; 14(24):6061-6. PubMed ID: 15546730
[TBL] [Abstract][Full Text] [Related]
16. Structure-based design and biological profile of (E)-N-(4-Nitrobenzylidene)-2-naphthohydrazide, a novel small molecule inhibitor of IκB kinase-β.
Avila CM; Lopes AB; Gonçalves AS; da Silva LL; Romeiro NC; Miranda AL; Sant'Anna CM; Barreiro EJ; Fraga CA
Eur J Med Chem; 2011 Apr; 46(4):1245-53. PubMed ID: 21334796
[TBL] [Abstract][Full Text] [Related]
17. Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways.
Verhaeghe C; Remouchamps C; Hennuy B; Vanderplasschen A; Chariot A; Tabruyn SP; Oury C; Bours V
Biochem Pharmacol; 2007 Jun; 73(12):1982-94. PubMed ID: 17466952
[TBL] [Abstract][Full Text] [Related]
18. Imidazo[4,5-d]thiazolo[5,4-b]pyridine based inhibitors of IKK2: synthesis, SAR, PK/PD and activity in a preclinical model of rheumatoid arthritis.
Dyckman AJ; Langevine CM; Quesnelle C; Kempson J; Guo J; Gill P; Spergel SH; Watterson SH; Li T; Nirschl DS; Gillooly KM; Pattoli MA; McIntyre KW; Chen L; McKinnon M; Dodd JH; Barrish JC; Burke JR; Pitts WJ
Bioorg Med Chem Lett; 2011 Jan; 21(1):383-6. PubMed ID: 21087862
[TBL] [Abstract][Full Text] [Related]
19. First asymmetric synthesis of CJ-14877 and its enantiomer and their interleukin-1beta inhibitory activities.
Aoyagi Y; Adachi Y; Akagi S; Ohno N; Takeya K
Bioorg Med Chem Lett; 2009 Apr; 19(7):1876-8. PubMed ID: 19272778
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of lipopolysaccharide-inducible nitric oxide synthase and IL-1beta through suppression of NF-kappaB activation by 3-(1'-1'-dimethyl-allyl)-6-hydroxy-7-methoxy-coumarin isolated from Ruta graveolens L.
Raghav SK; Gupta B; Shrivastava A; Das HR
Eur J Pharmacol; 2007 Mar; 560(1):69-80. PubMed ID: 17292351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
